Neurobiological Analyses Within the FORESEE III Study
Sponsor: German Center for Neurodegenerative Diseases (DZNE)
Listed as NCT04021823, this observational or N/A phase trial focuses on Treatment Resistant Depression and remains ongoing. Sponsored by German Center for Neurodegenerative Diseases (DZNE), it has been updated 8 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2023 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Dec 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- German Center for Neurodegenerative Diseases (DZNE)
- University Hospital Freiburg
- University Hospital, Bonn
- University Medical Center Freiburg
- University of Freiburg
For direct contact, visit the study record on ClinicalTrials.gov .